PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Sotalol and Diltiazem Interaction

Drug interaction information between Sotalol and Diltiazem.

Sotalol and Diltiazem have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Sotalol and Diltiazem. Major interactions are generally avoided, moderate ones may need monitoring or a dose adjustment, and minor ones are usually low-risk. This page shows the documented mechanism and guidance. Label-documented interactions are not a complete safety review, so always confirm your own medications with a pharmacist or doctor. Educational information, not medical advice.

Drug A

Sotalol

Class III Antiarrhythmic / Beta-Blocker

Drug B

Diltiazem

Calcium Channel Blocker

How They Interact

Both of these medicines slow down your heart rate and the electrical signals that travel through your heart.

What To Do

Your doctor should monitor your heart rate and pulse closely to make sure they do not become too slow.

FDA Label Information

7.2 Negative Chronotropes Digitalis glycosides, diltiazem, verapamil, and beta-blockers slow atrioventricular conduction and decrease heart rate.

Sotalol Also Interacts With

View all Sotalol interactions →

Frequently Asked Questions

Can I take Sotalol and Diltiazem together?

This is a minor interaction. Your doctor should monitor your heart rate and pulse closely to make sure they do not become too slow.

How serious is the interaction between Sotalol and Diltiazem?

This interaction is classified as "minor" severity by the FDA. Minor interactions are unlikely to cause significant problems but should still be mentioned to your healthcare provider.

Why do Sotalol and Diltiazem interact?

Both of these medicines slow down your heart rate and the electrical signals that travel through your heart.

Understanding the Sotalol and Diltiazem Interaction

FDA-approved prescribing information for these two drugs flags their combination as a minor-severity interaction. Sotalol belongs to the Class III Antiarrhythmic / Beta-Blocker class and Diltiazem belongs to the Calcium Channel Blocker class - two categories that can collide when co-prescribed. The mechanism described in FDA labeling is: Both of these medicines slow down your heart rate and the electrical signals that travel through your heart. Severity tiers matter: major flags generally advise avoidance, moderate flags often require monitoring or dose adjustment, and minor flags may only call for awareness.

Context around a specific patient determines real-world impact. Sotalol has 13 total documented interactions on file in this dataset, and Diltiazem has 46. Each additional medication compounds the interaction surface, which is why pharmacists run full-profile checks rather than evaluating one pair at a time. FDA-derived guidance for this pair is: Your doctor should monitor your heart rate and pulse closely to make sure they do not become too slow. Timing of doses, renal and hepatic function, age, and other concurrent prescriptions all shape whether a labeled interaction matters clinically.

An interaction flag is not a verdict. A large share of labeled interactions are managed routinely in clinical practice, the fix may be as simple as spacing doses or adding a monitoring test. Others require the prescriber to choose a different medication entirely. This page surfaces FDA-sourced labeling and openFDA data for educational purposes only; it is not medical advice and cannot account for your full clinical picture. Never start, stop, or adjust either Sotalol or Diltiazem based on a web page, speak with your prescriber or pharmacist before making any change.

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. Always consult your healthcare provider about drug interactions.